Viking Therapeutics (VKTX) Insider Trading & Ownership → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free VKTX Stock Alerts $79.91 +0.30 (+0.38%) (As of 05/8/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Viking Therapeutics (NASDAQ:VKTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$37.85 M Get VKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Viking Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VKTX Insider Buying and Selling by Quarter Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Viking Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/3/2024Greg ZanteCFOSell66,756$74.69$4,986,005.64 5/1/2024Marianna ManciniCOOSell281,425$78.66$22,136,890.50 2/8/2024Brian LianCEOSell269,079$26.87$7,230,152.73 2/8/2024Sarah Kathryn RouanDirectorSell25,000$28.05$701,250.00 1/30/2024Brian LianCEOSell35,000$23.95$838,250.00 1/19/2024Sarah Kathryn RouanDirectorSell30,000$23.05$691,500.00 1/4/2024Greg ZanteCFOSell15,000$17.90$268,500.00 5/16/2023Charles A Rowland JrDirectorSell40,000$25.00$1,000,000.00 (Data available from 1/1/2013 forward) VKTX Insider Trading Activity - Frequently Asked Questions Who is on Viking Therapeutics's Insider Roster? The list of insiders at Viking Therapeutics includes Brian Lian, Charles A Rowland Jr, Greg Zante, Lawson Macartney, Marianna Mancini, Matthew W Foehr, and Sarah Kathryn Rouan. Learn more on insiders at VKTX. What percentage of Viking Therapeutics stock is owned by insiders? 4.70% of Viking Therapeutics stock is owned by insiders. Learn more on VKTX's insider holdings. Which Viking Therapeutics insiders have been selling company stock? The following insiders have sold VKTX shares in the last 24 months: Brian Lian ($16,041,678.43), Charles A Rowland Jr ($1,000,000.00), Greg Zante ($9,201,706.64), Lawson Macartney ($767,720.00), Marianna Mancini ($23,046,762.50), and Sarah Kathryn Rouan ($1,392,750.00). How much insider selling is happening at Viking Therapeutics? Insiders have sold a total of 1,482,829 Viking Therapeutics shares in the last 24 months for a total of $51,450,617.57 sold. More Insider Trading Tools from MarketBeat Related Companies: ROIV Insider Ownership CERE Insider Ownership CTLT Insider Ownership JAZZ Insider Ownership ITCI Insider Ownership UTHR Insider Ownership ELAN Insider Ownership CYTK Insider Ownership IONS Insider Ownership BPMC Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:VKTX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.